Despite MacroGenics' stock price surge, its P/S ratio remain...
Despite MacroGenics' stock price surge, its P/S ratio remains modest due to inferior revenue forecasts. Without significant change, a drastic price rise is hard to envision.
MacroGenics, Inc. (NASDAQ:MGNX) Surges 34% Yet Its Low P/S Is No Reason For Excitement
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment